This study shows multiple sclerosis (MS) costs over $3 billion annually, driven by rising prevalence. MS is a chronic, incurable neurological disease that imposes growing social and economic burdens. The report provides recommendations for government with a focus on improving care, access and research.

New findings from this research report show that while the number of Australians living with Multiple Sclerosis (MS) continues to rise – now at 25,600 – the course of the disease is shifting, with more people able to stay in work and needing less care and support as a result of changes in treatment strategies.